跳至主要内容
临床试验/ISRCTN17751043
ISRCTN17751043已完成不适用

The efficacy, safety and cost-effectiveness analysis of morphine and hydromorphone in intrathecal drug deliver system for intractable cancer pain:a multicenter, randomized single-blind, controlled study.

Chinese association for the study of pain, the minimally invasive interventional group0 个研究点目标入组 240 人开始时间: 2016年1月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Cancer pain

排除标准

  • 1. Researchers think that there is any reason can't include
  • 2. IDDS procedure contraindications
  • 3. Uncooperative and unable to finish the self evaluation (PHQ - 9, GAD - 7 and SF-36)
  • 4. Spinal deformity, intolerance to operation
  • 5. The central infection, severe systemic infection
  • 6. The blood coagulation dysfunction; severe liver and kidney dysfunction
  • 7. Patient who has a history of drug abuse

研究者

发起方
Chinese association for the study of pain, the minimally invasive interventional group

相似试验